• Skip to primary navigation
  • Skip to main content
All endoscopic procedures at our clinic are billed No-Gap
Phone Us: (02) 8711 0160
snw-gastro-logo-01
  • Our Team
  • Services
    • Consultations
    • Direct Access Endoscopy
    • Colonoscopy
    • Gastroscopy
    • Capsule Endoscopy
    • Liver Fibroscan
  • Patient Info
    • New Patient Information
    • Preparing for your procedure
  • Contact Us
    • Locations
    • How to Refer
    • FAQ
    • Contact
×
  • Our Team
  • Services
    • Consultations
    • Direct Access Endoscopy
    • Colonoscopy
    • Gastroscopy
    • Capsule Endoscopy
    • Liver Fibroscan
  • Patient Info
    • New Patient Information
    • Preparing for your procedure
  • Contact Us
    • Locations
    • How to Refer
    • FAQ
    • Contact
Book Appointment
Search
Close
  • Our Team
  • Services
    • Consultations
    • Direct Access Endoscopy
    • Colonoscopy
    • Gastroscopy
    • Capsule Endoscopy
    • Liver Fibroscan
  • Patient Info
    • New Patient Information
    • Preparing for your procedure
  • Contact Us
    • Locations
    • How to Refer
    • FAQ
    • Contact

Intestinal Metaplasia

Home » Gastroscopy » Intestinal metaplasia
  • Helicobacter Treatment
  • Oesophageal Dilation
  • Reflux and Barrett’s Oesophagus
  • Helicobacter Treatment
  • Oesophageal Dilation
  • Reflux and Barrett’s Oesophagus

Intestinal Metaplasia (IM)

When cells in the stomach transform into intestinal cells this is called metaplasia and can be a precursor to cancer. Intestinal metaplasia tends to occur due to chronic inflammation and is associated with Helicobacter Pylori infection, autoimmune gastritis, smoking and certain ethnic backgrounds. IM is associated with an increased risk for gastric cancer, although the absolute risk remains low. Patients with clinically significant IM need monitoring with gastroscopy every 1-3 years.

Why is endoscopic monitoring needed?

Intestinal metaplasia progresses to cancer in a step-wise fashion usually over a number of years. This generally occurs as follows:

Intestinal metaplasia --(years)--> IM with low grade dysplasia --(months)--> IM with high grade dysplasia --(weeks to months)--> Cancer

By monitoring we aim to prevent the development of cancer and intervene if dysplasia is ever detected. 

What are risk factors for progression of IM to cancer?

 

  • Extensive IM vs limited
  • Family hx gastric cancer
  • Smoking
  • Racial risk for gastric ca (eg. Korean, Japanese)

Specialised services provided

  • Monitoring IM using high-definition gastroscopes and narrow band imaging
  • Advice on risk reduction
  • Referral for resection when required

Click on each image to view:

Book Appointment
sydney-nw-logo-rev-01
Monday - Friday
8:00 AM - 4:30 PM
Saturday - Sunday
Closed

(02) 8711 0160

(02) 8624 4769

[email protected]

Suite 4, 17-19 Solent Circuit, NORWEST, NSW 2153

© 2005-2025 Sydney Norwest Gastroenterology | All Rights Reserved

Terms & Conditions | Privacy Policy | Disclaimer

Book Appointment